26081-07-2,
(S)-3-Aminoazepan-2-one hydrochloride,
(S)-3-AMINO-2-OXO-AZEPANE HCL,
(S)-3-AMINO-AZEPAN-2-ONE HYDROCHLORIDE,
L(-)-Alpha-Amino-Epsilon-Caprolactam,
(S)-3-Amino-2-oxo-azepane hydrochloride,
2H-Azepin-2-one, 3-aminohexahydro-, monohydrochloride, (3S)-,
3-AMINOHEXAHYDRO-2H-AZEPIN-2-ONE HYDROCHLORIDE,
L-Lysine lactam hydrochloride,
SCHEMBL1114699,
CTK8B4682,
DTXSID50481421,
LWXJCGXAYXXXRU-JEDNCBNOSA-N,
BCP01251,
KS-00000C8S,
ANW-45881,
MFCD02683418,
(R)-3-Aminoazepan-2-oneHydrochloride,
AKOS007930009,
AKOS015998880,
ACM26081072,
(3S)-3-aminoazepan-2-one hydrochloride,
(5)-3-amino-azepan-2-one hydrochloride,
(R);-3-Aminoazepan-2-one hydrochloride,
AC-29490,
AK-86770,
AS-44383,
SC-47624,
AX8227234,
RT-004909,
ST2402814,
FT-0687400,
L-(-)-|A-Amino-|A-caprolactam hydrochloride,
L-(?)-|A-Amino-|A-caprolactam hydrochloride,
A56019,
L-(-)-alpha-Amino-?-caprolactam hydrochloride,
l-alpha-amino-epsilon-caprolactam hydrochloride,
Z-7915,
(S)-3-Amino-hexahydro-2-azepinone hydrochloride,
J-016246,
(3S)-3-Aminoazepan-2-one--hydrogen chloride (1/1),
2H-Azepin-2-one, 3-aminohexahydro-, hydrochloride (1:1), (3R)-,
2H-Azepin-2-one, 3-aminohexahydro-, hydrochloride (1:1), (3S)-,
L-(-)-alpha-Amino-epsilon-caprolactam hydrochloride, >=97.0% (AT),
3-aminoazepan-2-one,
A15430,
L-(-)-alpha-Amino-epsilon-caprolactam hydrochloride,
26081-03-8,